Inicio › Glioblastoma › Utah › Salt Lake City
Ensayos clínicos de Glioblastoma en Salt Lake City, UT
11 estudios para Glioblastoma buscan participantes en centros de Salt Lake City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
ReclutandoFase 3
- University of Utah, Hunstman Cancer Institute, Salt Lake City
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
ReclutandoFase 2/3
- University of Utah - Huntsman Cancer Institute, Salt Lake City
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
ReclutandoFase 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
ReclutandoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
ReclutandoFase 1
- Huntsman Cancer Institute/University of Utah, Salt Lake City
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
ReclutandoFase 3
- Huntsman Cancer Insititute, University of Utah, Salt Lake City
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
ReclutandoFase 2
- Huntsman Cancer Institute, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Reclutando
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ReclutandoFase 1/2
- University of Utah, Huntsman Cancer Institute, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Salt Lake City
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
ReclutandoFase 1
- University of Utah, Huntsman Cancer Institute, Salt Lake City
Ensayos de Glioblastoma en otras ciudades
- New York City, NY30 estudios
- Boston, MA28 estudios
- Houston, TX26 estudios
- Los Angeles, CA24 estudios
- Durham, NC20 estudios
- San Francisco, CA17 estudios
- Chicago, IL15 estudios
- Washington, DC15 estudios
- Miami, FL14 estudios
- Columbus, OH14 estudios
- Rochester, MN13 estudios
- Jacksonville, FL13 estudios
Otros estudios en Salt Lake City
- Cáncer de pulmón de células no pequeñas31 estudios
- Cáncer (todos los tipos)27 estudios
- Cáncer de seno27 estudios
- Cáncer del colon y del recto22 estudios
- Cáncer de pulmón21 estudios
- Melanoma21 estudios
- Mieloma múltiple21 estudios
- Cáncer metastásico20 estudios
- Cáncer de ovario19 estudios
- Obesidad18 estudios
- Leucemia mielógena aguda17 estudios
- Fallo cardíaco17 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.